Photo by atikahakhtar from unsplash
We read with extreme interest the evidence for an impressively high, comparable to current systemic therapies, dose related efficacy of indirubin in plaque psoriasis.1 Lin and co-authors1 appropriately discuss their… Click to show full abstract
We read with extreme interest the evidence for an impressively high, comparable to current systemic therapies, dose related efficacy of indirubin in plaque psoriasis.1 Lin and co-authors1 appropriately discuss their results, yet we would like to draw attention to a noteworthy aspect of the proposed therapeutic modality: The effectiveness of indirubin highlights the significance of the Malassezia metabolome in psoriasis, a long-term disputed issue.2 This article is protected by copyright. All rights reserved.
Journal Title: British Journal of Dermatology
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!